LivaNova (LIVN) Receivables - Other (2017 - 2025)

LivaNova's (LIVN) quarterly Receivables - Other came in at $600000.0 in Q4 2025, down 81.82% year-on-year from $3.3 million in Q4 2024, and down 93.75% quarter-over-quarter from $9.6 million in Q2 2025.

LivaNova (LIVN) Receivables - Other (2017 - 2025) Analysis & Trends

LivaNova has disclosed Receivables - Other across 4 years of filings, most recently posting $600000.0 for Q4 2025.

  • Receivables - Other for Q4 2025 came in at $600000.0, down 81.82% year-over-year; the trailing twelve-month figure through Dec 2025 was $600000.0 (down 81.82% YoY), and the FY2025 annual result was $600000.0, down 81.82% from the prior year.
  • Receivables - Other came in at $600000.0 for Q4 2025 at LivaNova, down from $9.6 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $9.6 million in Q2 2025 to a low of $600000.0 in Q4 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 LivaNova 4.29 Bn 3.71 Bn 243.75 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 600,000.00
Dec 31, 2025 600,000.00
Jun 30, 2025 9.60 Mn
Jun 30, 2025 9.60 Mn
Mar 31, 2025 8.60 Mn
Mar 31, 2025 8.60 Mn
Dec 31, 2024 3.30 Mn
Dec 31, 2024 3.30 Mn
Mar 31, 2018 2.00 Mn
Mar 31, 2018 2.00 Mn
Dec 31, 2017 1.00 Mn
Dec 31, 2017 1.00 Mn
Sep 30, 2017 4.06 Mn
Sep 30, 2017 4.06 Mn
Jun 30, 2017 4.82 Mn
Jun 30, 2017 4.82 Mn